期刊文献+

97例注射用磷霉素钠不良反应文献分析 被引量:5

Literature Analysis of 97 Cases of Adverse Drug Reaction Induced by Fosfomycin Sodium
下载PDF
导出
摘要 目的探讨注射用磷霉素钠所致不良反应的一般规律和特点,以期为临床安全用药提供参考。方法以"注射用磷霉素"并含"不良反应"为主要检索词,检索中国知网(CNKI)数据库1980年1月~2013年1月间报道的涉及注射用磷霉素钠所致不良反应的文献报道,分别从不良反应的发生时间、原患疾病、临床表现及预后等方面进行统计分析。结果共检索出33篇97例病例,不良反应累及系统-器官以皮肤及其附件损害为最多、其次为呼吸系统损害、全身性损害和心血管系统一般损害;主要临床表现为瘙痒、皮疹、呼吸困难、胸闷等;多数不良反应在停药或对症治疗处理后恢复正常。结论注射用磷霉素钠的不良反应累及系统-器官较少,不良反应预后良好,但临床仍应重视注射用磷霉素钠的不良反应,加强用药监测,确保用药安全。 Objective To analyze the general characteristics of adverse drug reaction induced by fosfomycin sodium, provide reference for rational drug use in clinic. Methods Using "fosfomycin sodium" and "adverse drug reaction" as the keywords, searched the cases of the adverse drug reaction induced by fosfomycin sodium which were reported from Jan 1980 to Jan 2013. The data were analyzed in terms of occurrence time, original disease, clinical manifestation, prognosis, et al. Results There were 33 publications including 97 cases. Skin and appendages disorders were with the highest in- cidence, followed by the respiratory system disorders, systematic disorders and cardiovascular disorders. The main clinical manifestations were pruritus, rash, dyspnea, sense of suppression in the chest, et al. Most of adverse drug reactions got right after drug withdrawal and symptomatic treatment. Conclusion The adverse drug reactions induced by fosfomycin sodium were low, and prognosis was well. Attention should be paid to the adverse drug reactions induced by fosfomycin sodium in chnic, and the monitoring of medication should also be strengthened to ensure the safe medication.
出处 《中国药物警戒》 2013年第9期560-562,566,共4页 Chinese Journal of Pharmacovigilance
关键词 磷霉素 药品不良反应 文献分析 fosfomycin adverse drug reaction literature analysis
  • 相关文献

参考文献8

  • 1Patel S S, Balfoud J A, Bryson H M. Fosfomycin tromethamine.Are view of its antibacterial activity, Pharmacokinetic Properties andtherapeutic efficacy as a single dose oral treatment for acute unco-mplicated lower urinary tract infections[J]. Drugs, 1997,53(4): 637.
  • 2黄祥,王健民,李勇.磷霉素的药动学药效学特性与临床应用[J].中国医院药学杂志,2005,25(2):156-158. 被引量:62
  • 3CFDA.国家药品不良反应监测年度报告[R]. (2012-5-30)[2013-6-10]. http://www.sdagov.cn/WS01/CL0001/search.html.2012.5-30.
  • 4范燕.磷霉素治疗小儿急性细菌性痢疾的疗效及不良反应文献分析[J].中国医药导报,2012,9(31):121-122. 被引量:10
  • 5唐彩娟 石建明 覃兰芬.磷霉素致剥脱性皮炎1例[J].右江民族医学院学报,2000,5:832-832.
  • 6王云琴,陈玉兰.磷霉素钠致急性肌张力障碍2例[J].药物不良反应杂志,2001,3(1):46.
  • 7林文正.静脉滴注磷霉素致过敏性休克死亡1例[J].浙江中西医结合杂志,2000,10(1): 54.
  • 8陈巧恩.磷霉素治疗小儿急性菌痢92例分析[J].社区医学杂志,2008,6(17):72-73. 被引量:3

二级参考文献22

  • 1高育林,包宇.磷霉素治疗小儿感染性腹泻疗效观察[J].中国社区医师,2006,22(10):25-25. 被引量:2
  • 2王冰月,包宇.磷霉素治疗小儿急性细菌性痢疾82例疗效分析[J].中国社区医师,2006,22(9):26-26. 被引量:1
  • 3国家药典委员会编.临床用药须知[M](第3版)[M].北京:化学工业出版社,2001.16-19.
  • 4陈新谦 金有豫.新编药物学[M].北京:人民卫生出版社,1998.113-114.
  • 5Patel SS, Balfoud JA, Bryson HM. Fosfomycin trornethamine Areviewof its antibacterial activity, Pharmacokinetic ProPerties and therapeutic efficacy as a single-dose oral treatment-for acute uncomplicated lower urinary tract infections[J]. Drugs, 1997, 53(4) :637.
  • 6Forestier F, salvanet-Bouccara-A,Leveques-D, et al. Ocular Penetration Kinetics of fosfomycin administered as a one-hour infusion[J]. Eur J Ophthalmol, 1996, 6(2):137.
  • 7Scaglione F,cicchetti F, Demartini G, et al. Fosfomycin distribution in the lower urinary tract after administration of fosfomycin trometamol salt[J]. Int J elin Pharmacol Res, 1994,14(3):107.
  • 8Legat FJ, Maier A, Dittrich P,et al. Penetration of fosfomycin into inflammatory Lesions in Patients with Cellulitis or diabetic foot syndrome[J]. Antimicrob Agents Chemother, 2003,47(1):371.
  • 9Kitamura K, Hirai H, Hosoya N,et al. Clinical efficacy of fosfomycin in combination with Sulbactam/cefoperazone in the treatment of Severe infections Complicated to blood dyscrasia. Working Group of Kanto Combination Therapy for FOM + SBV/cpz[J]. Kansens hogaku Z,asshi, 1998, 72(7):761.
  • 10Morikawa K,OseKO F,Morikawa S. Immunomodulatory effect of fosfomycin on human B-lymphocyte function[J]. Antimicrob Agent s Chemother, 1993,37 (2) : 270.

共引文献75

同被引文献44

  • 1凌静,冯友根,赵莉丽.磷霉素钠不良反应分析[J].中国现代应用药学,2005,22(z1):604-606. 被引量:3
  • 2王艳宁,钟慧.1994年~2004年磷霉素致过敏性休克文献分析[J].中国药房,2006,17(6):452-453. 被引量:4
  • 3范燕,裴斐,梁蓓蓓,童卫杭,刘建行,李鑫,董涛,蔡芸,王睿.磷霉素与五种氨基糖苷类抗菌药物对20株铜绿假单胞菌的联合药敏研究[J].中国药物应用与监测,2007,4(1):47-49. 被引量:7
  • 4卫生部合理用药专家委员会.中国医师药师临床用药指南[M].重庆:重庆出版集团重庆出版社,2009:700-701.
  • 5Venier AG,Lavigne T, Jarno P, et al. Nosocomial urinary tract infection in the intensive care unit: when should Pseudomonas aeruginosa be suspected? Experience of the French National surveillance of nosocomial infections in the intensive care unit, Rea-Raisin[J]. Clin Microbiol In- fect,2012,18(1) :13-15.
  • 6Karlowsky JA, Lagacfi-wiens PR,Simner PJ, et al. Anti- microbial resistance in urinary tract pathogens in Canada from 2007 to 2009: CANWARD surveillance study[J]. Antimicrob Agents Chemother, 2011,55 (7) : 3169-3175.
  • 7Kastoris AC, Rafailidis PI, Vouloumanou EK, et al. Syner- gy of fosfomyein with other antibiotics for Gram-positlve and Gram-negative bacteria [J]. Eur J Clin Pharmacol, 2010,66 (4) : 359-368.
  • 8Hernendez MS, Garcia JA, Mufioz JL. In vitro activity of fosfomycin against ESBL-producing enterobacteria of uri- nary origin[J].Rev Esp Quimioter,2009,22(1):25-29.
  • 9Michalopoulos AS, Livaditis IG, Gougoutas V. The revival of fosfo- mycin[ J]. Int J infect Dis ,2011,15 : e732 - e739.
  • 10Falagas ME, Maraki S, Karageorgopoulos DE, et al. Antimicmbial susceptibility of Gram - positive non - urinary isolates to fosfomycin [ J]. Int J Antimicrob Agents ,2010,35:497 -499.

引证文献5

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部